Protective arms of the renin-angiotensin-system in neurological disease

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 8, 2013, Pages 580-588

  Sumners, Colin ^a   Horiuchi, Masatsugu ^b   Widdop, Robert E ^c   Mccarthy, Claudia ^c   Unger, Thomas ^d   Steckelings, Ulrike M ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b EHIME UNIVERSITY   (Japan)

^c MONASH UNIVERSITY   (Australia)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Angiotensin (1 7) receptor; Angiotensin converting enzyme 2; AT2 receptor; Cognitive disorders; Receptor Mas; Renin angiotensin system; Stroke

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAS RECEPTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CASE REPORT; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; HUMAN; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPINAL CORD;

EID: 84881008963     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12137     Document Type: Review

References (76)

1. McKinley MJ, Albiston AL, Allen AM et al. The brain renin-angiotensin system: Location and physiological roles. Int. J. Biochem. Cell Biol. 2003; 35: 901-18.
2. Steckelings UM, Unger T. The renin-angiotensin-aldosterone system. In: Mancia G, Grassi G, Kjeldsen SE (eds). Manual of Hypertension of the European Society of Hypertension. Informa Healthcare, London. 2008; 110-16.
3. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am. J. Cardiol. 2002; 89: A3-10.
4. Tian M, Zhu D, Xie W, Shi J. Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. FEBS Lett. 2012; 586: 3737-45.
5. Mertens B, Vanderheyden P, Michotte Y, Sarre S. The role of the central renin-angiotensin system in Parkinson's disease. J. Renin Angiotensin Aldosterone Syst. 2010; 11: 49-56.
6. Mogi M, Iwanami J, Horiuchi M. Roles of brain angiotensin II in cognitive function and dementia. Int. J. Hypertens. 2012; 2012: 169649.
7. Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J. Mol. Med. 2008; 86: 715-22.
8. De Góis Queiroz AI, Medeiros CD, Ribeiro BMM, de Lucena DF, Macêdo DS. Angiotensin receptor blockers for bipolar disorder. Med. Hypotheses 2013; 80: 259-63.
9. 2 receptor: A matter of love and hate. Peptides 2005; 26: 1401-9.
10. Santos RAS, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system. J. Endocrinol. 2013; 216: R1-17.
11. Ferreira AJ, Santos RAS, Bradford CN et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 2010; 55: 207-13.
12. Bader M, Santos RA, Unger T, Steckelings UM. New therapeutic pathways in the RAS. J. Renin Angiotensin Aldosterone Syst. 2012; 13: 505-8.
13. 2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J. Biol. Chem. 1996; 271: 22729-35.
14. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell. Endocrinol. 1996; 122: 59-67.
15. 2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol. Endocrinol. 2007; 21: 499-511.
16. 2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol. Endocrinol. 1999; 13: 1615-26.
17. Côté F, Laflamme L, Payet MD, Gallo-Payet N. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr. Res. 1998; 24: 403-7.
18. 2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 1998; 188: 661-70.
19. 2 receptor and the transcription factor NF-kappaB. FASEB J. 2003; 17: 2094-6.
20. 2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol. Dis. 2013; 51: 177-91.
21. 2 receptor agonist. J. Med. Chem. 2004; 47: 5995-6008.
22. Anand U, Facer P, Yiangou Y et al. Angiotensin II type 2 receptor (AT(2)R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Eur. J. Pain. 2013; 17: 1012-26.
23. 2R) antagonists as novel analgesics for neuropathic pain. Comparative pharmacokinetics, radioligand binding, and efficacy in rats. Pain Med. 2013; 14: 692-705.
24. Dahlöf B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002; 359: 995-1003.
25. Iwai M, Liu H-W, Chen R et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004; 110: 843-8.
26. 2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005; 19: 617-19.
27. 2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 2009; 40: 1482-9.
28. McCarthy CA, Vinh A, Broughton BRS, Sobey CG, Callaway JK, Widdop RE. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension 2012; 60: 1531-7.
29. Lee S, Brait VH, Arumugam TV et al. Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo. Exp. Transl. Stroke Med. 2012; 4: 16.
30. 2 receptor exerts beneficial effects in stroke-prone rats: Focus on renal damage. J. Hypertens. 2009; 27: 2444-51.
31. 2 receptor agonist, to the striatum in rats. J. Neurosci. Methods 2011; 202: 137-42.
32. Zhao M-Z, Nonoguchi N, Ikeda N et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J. Cereb. Blood Flow Metab. 2006; 26: 1176-88.
33. Shen LH, Li Y, Chen J et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab. 2007; 27: 6-13.
34. Iwanami J, Mogi M, Tsukuda K et al. Effect of angiotensin II type 2 receptor deletion in hematopoietic cells on brain ischemia-reperfusion injury. Hypertension 2011; 58: 404-9.
35. Iwanami J, Mogi M, Li J-M et al. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008; 39: 2554-9.
36. 2-R./VEGFR-2 (Flk-1) interaction in the neonatal brain microvasculature for neuroprotection. Neuroscience 2012; 216: 1-9.
37. Xu P, Sriramula S, Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain. The axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011; 300: R804-17.
38. Becker LK, Etelvino GM, Walther T, Santos RAS, Campagnole-Santos MJ. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H1416-24.
39. Mecca AP, Regenhardt RW, O'Connor TE et al. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 2011; 96: 1084-96.
40. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004; 43: 970-6.
41. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998; 31: 699-705.
42. Kulemina LV, Ostrov DA. Prediction of off-target effects on angiotensin-converting enzyme 2. J. Biomol. Screen. 2011; 16: 878-85.
43. Sampaio WO, Nascimento AAS, Santos RAS. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H1985-94.
44. Feterik K, Smith L, Katusic ZS. Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery. Brain Res. 2000; 873: 75-82.
45. Iadecola C, Anrather J. The immunology of stroke: From mechanisms to translation. Nat. Med. 2011; 17: 796-808.
46. Regenhardt RW, Desland F, Mecca AP et al. Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 2013; 71C: 154-63.
47. Jiang T, Gao L, Guo J, Lu J, Wang Y, Zhang Y. Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 2012; 167: 1520-32.
48. 2, and AT4 and their functions. Regul. Pept. 1995; 59: 269-95.
49. 2 receptor in the acute phase of stroke in rats. NeuroReport 2000; 11: 1191-4.
50. Vervoort VS, Beachem MA, Edwards PS et al. AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401-3.
51. Wright JW, Reichert JR, Davis CJ, Harding JW. Neural plasticity and the brain renin-angiotensin system. Neurosci. Biobehav. Rev. 2002; 26: 529-52.
52. Côté F, Do TH, Laflamme L, Gallo JM, Gallo-Payet N. Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J. Biol. Chem. 1999; 274: 31686-92.
53. Mogi M, Li J-M, Iwanami J et al. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006; 48: 141-8.
54. Maul B, von Bohlen und Halbach O, Becker A et al. Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice. J. Mol. Med. 2008; 86: 563-71.
55. Tota S, Hanif K, Kamat PK, Najmi AK, Nath C. Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacology 2012; 222: 185-202.
56. 4 receptors. J. Hypertens. 2008; 26: 2008-15.
57. Jing F, Mogi M, Sakata A et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J. Cereb. Blood Flow Metab. 2012; 32: 248-55.
58. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martínez A, Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J. Biol. Chem. 2005; 280: 21453-62.
59. Wang N, Verna L, Chen N-G et al. Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J. Biol. Chem. 2002; 277: 34176-81.
60. Klotz L, Sastre M, Kreutz A et al. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J. Neurochem. 2003; 86: 907-16.
61. Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B. Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J. Neurosci. 2004; 24: 10908-17.
62. Nakamura T, Yamamoto E, Kataoka K et al. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 2007; 38: 3016-22.
63. Wada K, Nakajima A, Katayama K et al. Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 2006; 281: 12673-81.
64. Zhao Y, Foryst-Ludwig A, Bruemmer D et al. Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. J. Neurochem. 2005; 94: 1395-401.
65. Ohshima K, Mogi M, Jing F et al. Direct angiotensin ii type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation. PLoS One 2012; 7: e48387.
66. Lu J, Zhang Y, Shi J. Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats. Brain Res. 2008; 1219: 127-35.
67. Zhang Y, Lu J, Shi J et al. Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 2008; 42: 593-600.
68. Hellner K, Walther T, Schubert M, Albrecht D. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol. Cell. Neurosci. 2005; 29: 427-35.
69. Lazaroni TLN, Raslan ACS, Fontes WRP et al. Angiotensin-(1-7)/Mas axis integrity is required for the expression of object recognition memory. Neurobiol. Learn. Mem. 2012; 97: 113-23.
70. Platten M, Youssef S, Hur EM et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc. Natl Acad. Sci. USA 2009; 106: 14948-53.
71. Stegbauer J, Lee D-H, Seubert S et al. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc. Natl Acad. Sci. USA 2009; 106: 14942-7.
72. Kawajiri M, Mogi M, Higaki N et al. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Mult. Scler. 2009; 15: 262-5.
73. 2-receptor stimulation improves neurological outcome in a mouse model of multiple sclerosis. In: Proceedings of the 24th Meeting of the International Society of Hypertension (ISH). 2012; Available from: http://www.ish2012.org/docs/01%20ISH%202012%20Journal%20of%20Hypertension.pdf, (accessed 24 June 2013).
74. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc. Res. 2011; 92: 401-8.
75. Rompe F, Artuc M, Hallberg A et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 2010; 55: 924-31.
76. Jiang T, Gao L, Shi J, Lu J, Wang Y, Zhang Y. Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol. Res. 2012; 67: 84-93.